PD-L1 monitoring score card after minute 31:30:
Post# of 157771

*CRC
*mTNBC
*Glioblastoma w/o options.
"Through our eIND program" :
*Pancreatic
*Prostate
*Sarcoma
*Urothelial cancers -- (most common are bladder/kidney)
Dr. J, you, sir, are on top of Leronlimab affecting tumors Cold-to-Hot !
THANK YOU and BOOOM !!!....

